New large-capacity bioprocessing centrifuge enhances productivity and reliability
Thermo Scientific Sorvall BIOS 16 centrifuge designed to provide simplified, flexible bioprocessing.
Designed to maximize productivity for bioprocessing customers, the new Thermo Scientific Sorvall BIOS 16 centrifuge offers an increased capacity of up to 16 liters of cell culture product per run and unique design features to make working with large volumes easier and more convenient.
In the increasingly complex, regulated and fast-paced bioprocessing environment, users require a centrifuge with simple operation and high-throughput capabilities that deliver run-to-run reproducibility while maintaining sample integrity. These elements are essential to manufacturing products in a scalable, consistent and safe manner. In the development and manufacturing of biological products, centrifuges that support separation and purification processes are typically larger and are used continuously. Therefore, users put a high priority on ergonomically designed platforms.
The Thermo Scientific Sorvall BIOS 16 centrifuge includes several features designed to enhance the user experience, including
“For more than 60 years, Thermo Fisher Scientific has demonstrated application expertise across its centrifuge systems, and the addition of the Sorvall BIOS 16 bioprocessing centrifuge builds upon that commitment to delivering innovative designs to meet specific user needs,” said Monica Manotas, vice president and general manager, growth, protection and separation products at Thermo Fisher Scientific. “Now, bioprocessing centers around the world can reap the benefits of this unique, user-friendly system designed to provide high-throughput sample processing, simple, quick set-up and remote monitoring, energy savings, compliance with global safety standards and enhanced ergonomics with every run.”
The new Sorvall BIOS 16 bioprocessing centrifuge offers the flexibility to select higher-capacity rotors or match existing workflows, with a choice of four swinging bucket rotors ranging from 6 x 1000 mL to 8 x 2000 mL. This product is listed with the FDA and complies with the latest global safety standards including UL and CE.
Related News
-
News Moderna to buy OriCiro Genomics in USD $85 million deal
Pharmaceutical company Moderna acquires genomics services company OriCiro Genomics, based in Tokyo, Japan, to boost mRNA therapeutics development and manufacturing portfolio. -
News New year, new prices: at least 350 drugs in USA to see price increases in January
Drugmakers such as Pfizer, GSK, BMS, AstraZeneca, and Sanofi are planning to raise prices for at least 350 unique drugs in the United States in early January. -
Sponsored Content 2023 Pharma Trend Outlook: Innovation, Resilience, and Pharma 4.0
Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain. -
News Strategic partnership between AstraZeneca and G42 Healthcare to increase pharmaceutical manufacturing in Abu Dhabi
A comprehensive, long-term partnership agreement between AstraZeneca and G42 Healthcare is set to enhance local drug manufacturing in Abu Dhabi, UAE, and bolster pharmaceutical manufacturing innovation within the country. -
News CordenPharma joins sustainability initiative to achieve Net Zero
The CDMO has joined the environmental initiative looking to align private sector companies with those aims upheld by the Paris Agreement to reduce global warming. -
News AstraZeneca acquires Neogene in shift into cell-based cancer therapies
AstraZeneca has recently announced that it will be acquiring the biotechnology company Neogene Therapeutics as part of it’s expansion into cell-based cancer treatments.
-
News A mRNA universal flu vaccine is in early stages of development
Researchers from the University of Pennsylvania have developed a universal flu vaccine using nanoparticle encapsulated mRNA. -
News Biovac partnership to increase African vaccine manufacturing capabilities
South African biopharma company Biovac signs a partnership deal with the International Vaccine Institute to develop and manufacture an oral cholera vaccine for both the African and global market.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance